F Hafner, G Thomas, H Froehlich, K Steidl, M Brodmann. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, OralAdultAgedAged, 80 and overBosentanDrug Therapy, CombinationFemaleFingersHumansIloprost/administration & dosageInfusions, IntravenousMaleMiddle AgedRetrospective StudiesScleroderma, Systemic/complicationsSkin Ulcer/drug therapySkin Ulcer/etiologySkin Ulcer/pathologySulfonamides/administration & dosageTime FactorsTreatment OutcomeVasodilator Agents/administration & dosageWound Healing/drug effectsYoung Adult
Substances： See more » SulfonamidesVasodilator AgentsIloprostBosentan
Year: 2011 PMID： 21804491
Source DB: PubMed Journal: Int Angiol ISSN： 0392-9590 Impact factor: 2.789